HomeCompareAUD vs PFE

AUD vs PFE: Dividend Comparison 2026

AUD yields 5299.15% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AUD wins by $744.20M in total portfolio value
10 years
AUD
AUD
● Live price
5299.15%
Share price
$0.09
Annual div
$4.96
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$744.25M
Annual income
$19,077,020.21
Full AUD calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — AUD vs PFE

📍 AUD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAUDPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AUD + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AUD pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AUD
Annual income on $10K today (after 15% tax)
$450,427.35/yr
After 10yr DRIP, annual income (after tax)
$16,215,467.18/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, AUD beats the other by $16,192,338.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AUD + PFE for your $10,000?

AUD: 50%PFE: 50%
100% PFE50/50100% AUD
Portfolio after 10yr
$372.15M
Annual income
$9,552,115.38/yr
Blended yield
2.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

AUD
Analyst Ratings
1
Buy
1
Hold
1
Sell
Consensus: Buy
Price Target
$2.00
+2036.8% upside vs current
Range: $2.00 — $2.00
Altman Z
-2.7
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AUD buys
0
PFE buys
0
No recent congressional trades found for AUD or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAUDPFE
Forward yield5299.15%6.20%
Annual dividend / share$4.96$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%13.2%
Portfolio after 10y$744.25M$51.1K
Annual income after 10y$19,077,020.21$27,210.54
Total dividends collected$569.36M$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold
Analyst price target$2.00$27.50

Year-by-year: AUD vs PFE ($10,000, DRIP)

YearAUD PortfolioAUD Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$275,657$264,957.26$9,161$701.38+$266.5KAUD
2$3,707,916$3,412,962.38$8,610$859.79+$3.70MAUD
3$25,419,981$21,452,510.94$8,366$1,081.25+$25.41MAUD
4$95,923,585$68,724,205.59$8,483$1,405.66+$95.92MAUD
5$223,822,475$121,184,238.97$9,084$1,907.24+$223.81MAUD
6$371,622,854$132,132,806.30$10,418$2,732.78+$371.61MAUD
7$500,153,388$102,516,933.44$13,007$4,193.56+$500.14MAUD
8$599,637,831$64,473,705.83$18,010$7,005.87+$599.62MAUD
9$677,733,055$36,120,576.20$28,216$12,979.89+$677.70MAUD
10$744,251,389$19,077,020.21$51,081$27,210.54+$744.20MAUD

AUD vs PFE: Complete Analysis 2026

AUDStock

Audacy, Inc., a multi-platform audio content and entertainment company, engages in the radio broadcasting business in the United States. The company owns and operates radio stations in various formats, such as news, sports, talk, classic rock, urban, adult contemporary, alternative, country, and others, as well as offers integrated marketing solutions across its broadcast, digital, podcast, and event platforms. It also creates live and original events, including concerts and live performances, and crafted food and beverage events. The company was formerly known as Entercom Communications Corp. and changed its name to Audacy, Inc. in April 2021. Audacy, Inc. was founded in 1968 and is headquartered in Philadelphia, Pennsylvania.

Full AUD Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this AUD vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AUD vs SCHDAUD vs JEPIAUD vs OAUD vs KOAUD vs MAINAUD vs JNJAUD vs MRKAUD vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.